Ono Posts ¥95.60 IFRS Interim EPS as Six-Month Revenue Falls 9.6%

Ono Pharmaceutical Co., Ltd. recorded ¥95.60 in basic interim earnings per share under IFRS for the six months ended Sept. 30, 2026. Revenue for the same period was ¥232.5 billion, down 9.6% from a year earlier.

Operating profit increased 11.2% year over year to ¥57.91 billion. Core operating profit rose 5.1% to ¥73.63 billion.

For the fiscal year ending March 31, 2027, Ono forecasts consolidated revenue of ¥455 billion and operating profit of ¥94 billion. The operating profit outlook is on an IFRS basis.